UDG Healthcare Stock Forecast, Price & News

0.00 (0.00 %)
(As of 06/17/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Average Volume1,064 shs
Market Capitalization$2.89 billion
P/E Ratio24.23
Dividend Yield1.62%
30 days | 90 days | 365 days | Advanced Chart
Receive UDHCF News and Ratings via Email

Sign-up to receive the latest news and ratings for UDG Healthcare and its competitors with MarketBeat's FREE daily newsletter.

UDG Healthcare logo

About UDG Healthcare

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. This segment supports healthcare professionals and patients at various stages of the product life cycle; and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information, and event management services to approximately 300 healthcare companies. The Sharp segment provides contract and clinical trial packaging services for the pharmaceutical and biotechnology industries; serialization solutions; and clinical IRT services. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is heaquartered in Dublin, the Republic of Ireland.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.24 out of 5 stars

Medical Sector

798th out of 2,100 stocks

Private Households Industry

48th out of 381 stocks

Analyst Opinion: 0.0Community Rank: 1.8Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

UDG Healthcare (OTCMKTS:UDHCF) Frequently Asked Questions

Is UDG Healthcare a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for UDG Healthcare in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" UDG Healthcare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in UDHCF, but not buy additional shares or sell existing shares.
View analyst ratings for UDG Healthcare
or view top-rated stocks.

What stocks does MarketBeat like better than UDG Healthcare?

Wall Street analysts have given UDG Healthcare a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but UDG Healthcare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has UDG Healthcare's stock price been impacted by Coronavirus (COVID-19)?

UDG Healthcare's stock was trading at $9.6650 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, UDHCF stock has increased by 20.3% and is now trading at $11.63.
View which stocks have been most impacted by COVID-19

Is UDG Healthcare a good dividend stock?

UDG Healthcare pays an annual dividend of $0.19 per share and currently has a dividend yield of 1.62%. The dividend payout ratio of UDG Healthcare is 39.58%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, UDG Healthcare will have a dividend payout ratio of 31.67% next year. This indicates that UDG Healthcare will be able to sustain or increase its dividend.
View UDG Healthcare's dividend history.

Who are UDG Healthcare's key executives?

UDG Healthcare's management team includes the following people:
  • Mr. Brendan Patrick McAtamney, CEO & Exec. Director (Age 58, Pay $1.5M)
  • Mr. Nigel Clerkin, CFO & Exec. Director (Age 47, Pay $1.05M)
  • Mr. Ryan Quigley, Chief Operating Officer
  • Keith Byrne, Head of Investor Relations, Strategy & Corp. Communications
  • Eleanor Garvey, Group Head of Quality & Compliance
  • Mr. Damien Moynagh, Gen. Counsel & Company Sec.
  • Mr. Liam Logue, Exec. VP of Corp. Devel.
  • Ms. Lucy MacLauchlan-Wharton, Global Head of Marketing and Communications
  • Ms. Eimear Kenny, Exec. VP of HR (Age 51)
  • Mr. Tom Mitchell, Uk Head of Syndicated Services for Ashfield

Who are some of UDG Healthcare's key competitors?

What is UDG Healthcare's stock symbol?

UDG Healthcare trades on the OTCMKTS under the ticker symbol "UDHCF."

How do I buy shares of UDG Healthcare?

Shares of UDHCF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is UDG Healthcare's stock price today?

One share of UDHCF stock can currently be purchased for approximately $11.63.

How much money does UDG Healthcare make?

UDG Healthcare has a market capitalization of $2.89 billion and generates $1.28 billion in revenue each year. The company earns $92.83 million in net income (profit) each year or $0.48 on an earnings per share basis.

How many employees does UDG Healthcare have?

UDG Healthcare employs 9,000 workers across the globe.

What is UDG Healthcare's official website?

The official website for UDG Healthcare is www.udghealthcare.com.

Where are UDG Healthcare's headquarters?

UDG Healthcare is headquartered at 20 Riverwalk Citywest Business Campus Citywest, Dublin L2, 24.

How can I contact UDG Healthcare?

UDG Healthcare's mailing address is 20 Riverwalk Citywest Business Campus Citywest, Dublin L2, 24. The company can be reached via phone at 353-1468-9000 or via email at [email protected]

This page was last updated on 6/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.